| Ann Davidson Sheerin, LPC | |
|
200 Westpark Dr Ste 130, Peachtree City, GA 30269-1447 | |
| (404) 747-7709 | |
| Not Available |
| Full Name | Ann Davidson Sheerin |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 200 Westpark Dr Ste 130, Peachtree City, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023519477 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | LPC009852 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ann Davidson Sheerin, LPC 413 Deergrass Trl, Peachtree City, GA 30269-3411 Ph: (706) 766-1314 | Ann Davidson Sheerin, LPC 200 Westpark Dr Ste 130, Peachtree City, GA 30269-1447 Ph: (404) 747-7709 |
News Archive
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2014.
UCB today announced new findings on its antiepileptic drug (AED) Vimpat® that offer additional clinical evidence supporting the use of this AED as adjunctive therapy in adult patients with partial-onset seizures. Results of presented research demonstrate sustained efficacy in adult patients taking Vimpat® for up to three years, and a consistent long-term tolerability profile.
Today on World Malaria Day, the United Against Malaria campaign, under the Roll Back Malaria Partnership, recognized leaders from Africa's football and corporate spheres for their role in bringing malaria control messages to more than two billion 2010 World Cup spectators through public service announcements and media, and to 10 million employees through "Malaria Safe" corporate initiatives.
The German Institute for Quality and Efficiency in Health Care already assessed the added benefit of ipilimumab in advanced melanoma in 2012. A considerable added benefit was found for patients who had already received previous treatment. In the new dossier compiled by the drug manufacturer, the drug was now compared with the appropriate comparator therapy dacarbazine specified by the Federal Joint Committee (G-BA) also for non-pretreated patients.
...while those same levels don't change in their Caucasian counterparts, says new University of Alberta research that shows puberty is a key developmental period affecting diabetes risk.
› Verified 1 days ago
Abigail Drew Abel, Counselor Medicare: Not Enrolled in Medicare Practice Location: 211 Prime Pt, Building 2 Suite D, Peachtree City, GA 30269 Phone: 678-788-6025 | |
Keishla Suazo-padilla, Counselor Medicare: Not Enrolled in Medicare Practice Location: 200 Westpark Dr Ste 325, Peachtree City, GA 30269 Phone: 770-632-5444 | |
Tonya Gilmore, Counselor Medicare: Not Enrolled in Medicare Practice Location: 317 Welton Way, Peachtree City, GA 30269 Phone: 678-852-8024 | |
Sathiya Priya Palanisamy, Counselor Medicare: Not Enrolled in Medicare Practice Location: 6000 Shakerag Hl Ste 314, Peachtree City, GA 30269 Phone: 404-977-6712 | |
Crystal Johnson, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1303 Commerce Dr, Peachtree City, GA 30269 Phone: 770-862-6088 | |
Ashley Ann Bonvillain, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 23 Eastbrook Bnd, Suite 200, Peachtree City, GA 30269 Phone: 770-486-1140 Fax: 678-669-2693 |